MedPath

A Novel Oral Natural Extract for the Treatment of Senile Purpura

Not Applicable
Conditions
PURPURA
Interventions
Dietary Supplement: Calcium Carbonate
Dietary Supplement: Citrus Bioflavanoid Blend
Registration Number
NCT01183910
Lead Sponsor
Nexgen Dermatologics, Inc.
Brief Summary

A randomized, double-blind, placebo controlled study to assess the safety and effectiveness of a novel oral natural extract to improve the appearance of the skin of patients with senile purpura.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
75
Inclusion Criteria
  • Patients with evidence of purpura on physical exam
Exclusion Criteria
  • Preexisting condition that would not allow the patients to take oral calcium supplement

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Calcium carbonate placebo pillCalcium CarbonatePlacebo medication to treat the appearance of the skin in patients with senile purpura
NutraceuticalCitrus Bioflavanoid BlendPatients take a novel, natural nutraceutical product to improve the appearance of the skin of patients with senile purpura
Primary Outcome Measures
NameTimeMethod
IMPROVEMENT IN PATIENT'S SKIN APPEARANCE WITH SENILE PURPURA6 WEEKS
Secondary Outcome Measures
NameTimeMethod
ADVERSE EFFECTS IN PATIENTS WITH SENILE PURPURA TAKING THIS MEDICATION6 WEEKS

Trial Locations

Locations (1)

Berlin Center of Medical Aesthetics

🇺🇸

Boynton Beach, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath